CTOs on the Move

International Biometric Group

www.ibgweb.com

 
International Biometric Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ibgweb.com
  • 1 Battery Park Plz Ste 2901
    New York, NY USA 10004
  • Phone: 212.809.9491

Executives

Name Title Contact Details

Similar Companies

Floss Bar

Workplace Health, Starts with a Smile

Hospice of Southern Maine

Calling Hospice of Southern Maine doesn`t mean you`re giving up, it means you`re taking charge. At Hospice of Southern Maine, our mission is to provide compassion, care and comfort through the end of life for patients with a terminal illnesses and their families. We care for patients where they are, whether at home, in a long-term care and assisted living center, or at Gosnell Memorial Hospice House, our 18-bed facility in Scarborough.

BioAbility

BioAbility is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cuattro

Cuattro LLC is a Pekin, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.